Letrozole
FDA status: FDA has approved products that contain letrozole, including Femara.
PubMed: 4,994 publications mention Letrozole, 728 of them trials or reviews. Search PubMed
- Therapeutic management in women with a diminished ovarian reserve: a systematic review and meta-analysis of randomized controlled trials. Conforti A et al. Fertility and sterility, 2025. Systematic Review, Meta-Analysis. PMID 39332623 · DOI
- Palbociclib and Letrozole in Advanced Breast Cancer. Finn RS et al. The New England journal of medicine, 2016. Clinical Trial, Phase III, Randomized Controlled Trial. PMID 27959613 · DOI
- Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer. Hortobagyi GN et al. Annals of oncology : official journal of the European Society for Medical Oncology, 2018. Clinical Trial, Phase III, Randomized Controlled Trial. PMID 29718092 · DOI
- Breast cancer pharmacogenetics: a systematic review. Scudeler MM et al. Pharmacogenomics, 2023. Systematic Review. PMID 36475975 · DOI
- Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer. Hortobagyi GN et al. The New England journal of medicine, 2016. Clinical Trial, Phase III, Randomized Controlled Trial. PMID 27717303 · DOI
ClinicalTrials.gov: 902 registered studies. See all studies
- NCT02296801 A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer (Phase 2), completed
- NCT05337657 A Phase Ib Study of GB491 Plus Letrozole in Patients With Advanced Breast Cancer (Phase 1), unknown
MedlinePlus drug information ↗FDA label (DailyMed) ↗RxNorm 72965 ↗PubChem CID 3902 ↗Wikipedia ↗









